Clinical Trial Update: Apixaban for Intrahepatic Non Cirrhotic Portal Hypertension [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating apixaban for intrahepatic noncirrhotic portal hypertension is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Noncirrhotic Portal Hypertension

Drugs mentioned

• Eliquis (apixaban)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Intrahepatic Non Cirrhotic Portal Hypertension | Phase 3 | Status: ACTIVE_NOT_RECRUITING